IVC Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,233
Closed -$203K 182
2026
Q1
$203K Buy
+7,233
New +$193K 0.09% 171
2025
Q4
Sell
-9,105
Closed -$232K 188
2025
Q3
$232K Sell
9,105
-1,084
-11% -$26.8K 0.1% 161
2025
Q2
$247K Sell
10,189
-367
-3% -$8.56K 0.12% 146
2025
Q1
$267K Buy
10,556
+80
+0.8% +$2.09K 0.14% 131
2024
Q4
$278K Sell
10,476
-1,479
-12% -$40.1K 0.16% 127
2024
Q3
$346K Sell
11,955
-1,648
-12% -$48.1K 0.19% 108
2024
Q2
$381K Buy
13,603
+923
+7% +$25.4K 0.21% 102
2024
Q1
$352K Sell
12,680
-1,100
-8% -$30.5K 0.2% 107
2023
Q4
$397K Sell
13,780
-7,774
-36% -$235K 0.25% 90
2023
Q3
$715K Sell
21,554
-1,311
-6% -$46.4K 0.48% 54
2023
Q2
$839K Buy
22,865
+183
+0.8% +$7.12K 0.53% 52
2023
Q1
$925K Sell
22,682
-676
-3% -$29.2K 0.66% 40
2022
Q4
$1.2M Buy
23,358
+186
+0.8% +$8.92K 0.88% 27
2022
Q3
$1.01M Buy
23,172
+1,768
+8% +$85.9K 0.82% 30
2022
Q2
$1.12M Sell
21,404
-85
-0.4% -$4.33K 0.87% 27
2022
Q1
$1.11M Buy
21,489
+675
+3% +$35K 0.73% 31
2021
Q4
$1.23M Sell
20,814
-441
-2% -$21.9K 0.79% 30
2021
Q3
$914K Buy
21,255
+676
+3% +$29.9K 0.63% 41
2021
Q2
$806K Buy
20,579
+55
+0.3% +$2.14K 0.57% 50
2021
Q1
$744K Buy
20,524
+500
+2% +$17.8K 0.59% 48
2020
Q4
$737K Buy
+20,024
New +$734K 0.7% 41

Other funds holding PFE

IVC Wealth Advisors's PFE Position: Q2 2026 in Review

IVC Wealth Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,233 shares — an estimated $203K sold.

IVC Wealth Advisors first reported a position in PFE in Q4 2020 and held it in 21 quarters. The position peaked at $1.23M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • IVC Wealth Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • IVC Wealth Advisors sold 7,233 Pfizer shares in Q2 2026, an estimated $203K.
  • IVC Wealth Advisors first reported a position in Pfizer in Q4 2020 and held it in 21 quarters.
  • IVC Wealth Advisors's Pfizer position peaked at $1.23M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on IVC Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.